New findings could open the doors for the development of treatments for chronic pain.
Researchers discover proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as a target for new therapies.
··2 min read
Student and prof. study suspected link to hyper-excitability factors in epilepsy, autism and more. A UT Dallas undergraduate’s research is...